YU33795B - Process for preparing iysergic acid amides - Google Patents

Process for preparing iysergic acid amides

Info

Publication number
YU33795B
YU33795B YU933/68A YU93368A YU33795B YU 33795 B YU33795 B YU 33795B YU 933/68 A YU933/68 A YU 933/68A YU 93368 A YU93368 A YU 93368A YU 33795 B YU33795 B YU 33795B
Authority
YU
Yugoslavia
Prior art keywords
iysergic
preparing
acid amides
amides
acid
Prior art date
Application number
YU933/68A
Other languages
English (en)
Other versions
YU93368A (en
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of YU93368A publication Critical patent/YU93368A/xx
Publication of YU33795B publication Critical patent/YU33795B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06Lysergic acid amides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
YU933/68A 1967-04-20 1968-04-18 Process for preparing iysergic acid amides YU33795B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HUGO001012 1967-04-20
HUGO001028 1967-09-15

Publications (2)

Publication Number Publication Date
YU93368A YU93368A (en) 1977-10-31
YU33795B true YU33795B (en) 1978-05-15

Family

ID=26318471

Family Applications (1)

Application Number Title Priority Date Filing Date
YU933/68A YU33795B (en) 1967-04-20 1968-04-18 Process for preparing iysergic acid amides

Country Status (9)

Country Link
US (1) US3822268A (xx)
AT (1) AT298685B (xx)
CH (1) CH496010A (xx)
DE (1) DE1770227A1 (xx)
DK (1) DK117501B (xx)
GB (1) GB1227006A (xx)
NL (1) NL6805605A (xx)
SE (1) SE342817B (xx)
YU (1) YU33795B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU172649B (hu) * 1975-04-24 1978-11-28 Gyogyszerkutato Intezet Sposob poluchenija novykh biologicheski aktivnykh lizergamidov
US5441961A (en) * 1992-08-27 1995-08-15 Eli Lilly And Company Substituted cyclo or bicycloalkylamides of (8β)-6-(substituted) ergolines
JP2016503795A (ja) * 2012-12-21 2016-02-08 マップ ファーマシューティカルズ インコーポレイテッド 新規メチセルジド誘導体
BR112017015487A2 (pt) 2015-01-20 2018-01-30 Xoc Pharmaceuticals Inc Composto; composição; método de tratamento e/ou prevenção de enxaqueca, als, doença de alzheimer, doença de parkinson, distúrbios extrapirimidais, depressão, náusea, êmese, síndrome das pernas inquietas, insônia, agressão, doença de huntington, doença cardiopulmonar, fibrogênese, hipertensão arterial pulmonar, ansiedade, dependências a drogas, distonia, parassonia ou hiperlactinemia em um indivíduo; métodos de agonização dos receptores d2, 5-ht1d, 5-ht1a e 5-ht2c, em um indivíduo; método de antagonização do receptor d3 em um indivíduo; métodos de agonização seletiva dos receptores 5 -ht1d, e 5-ht2c, método de fornecimento de atividade de antagonista funcional no receptor 5 -ht2b ou no receptor 5-ht7, ou em ambos, em um indivíduo; método de fornecimento de atividade de antagonista funcional nos receptores adrenérgicos em um indivíduo
MX2017009406A (es) 2015-01-20 2018-01-18 Xoc Pharmaceuticals Inc Compuestos de tipo isoergolina y usos de estos.
CN105085514B (zh) * 2015-08-19 2016-09-28 河北智同医药控股集团有限公司 马来酸甲麦角新碱化合物及其制备方法
BR112019025420A2 (pt) 2017-06-01 2020-06-16 Xoc Pharmaceuticals, Inc. Compostos policíclicos e usos destes

Also Published As

Publication number Publication date
YU93368A (en) 1977-10-31
DK117501B (da) 1970-05-04
CH496010A (de) 1970-09-15
NL6805605A (xx) 1968-10-21
SE342817B (xx) 1972-02-21
AT298685B (de) 1972-05-25
DE1770227A1 (de) 1972-03-30
GB1227006A (xx) 1971-03-31
US3822268A (en) 1974-07-02

Similar Documents

Publication Publication Date Title
YU34657B (en) Process for preparing benzoyl-3-phenyl-acetic acid derivatives
YU237674A (en) Process for preparing novel 1-phenoxy2hydroxy-3-alkylamino-propanes
YU34138B (en) Process for preparing novel halo-pregnanedienes
YU69473A (en) Process for preparing substituted acetylguanidines
YU34400B (en) Process for preparing bis-thioureido-benzenes
YU93368A (en) Process for preparing iysergic acid amides
YU292769A (en) Process for preparing apovincamine acid amides
YU183368A (en) Process for preparing 7-aminocephalosporinic acid and derivatives thereof
YU228874A (en) Process for preparing novel substituted 1-phenoxy-2-hydroxy-3-tert.-butylamino-propanes
IL30625A0 (en) Process for preparing carboxylic acid thioanhydrides
YU260868A (en) Process for preparing d-trans-pyrethric acid
YU256373A (en) Process for preparing novel 3-amino-acylamino-thiophens
YU163373A (en) Process for preparing ethyl-aubstituted 1-phenoxy-2-hydroxy-3-alkylaminopropanes
YU202168A (en) Process for preparing 2,3-dichlore-4-butyryl-phenoxyaacetic acid
YU257568A (en) Process for preparing novel 7-methyl-steroids
YU189867A (en) Process for preparing 4-hydroxy-3-quinoline-carboxylic acid derivatives
YU34109B (en) Process for preparing acrylophenones
YU34085B (en) Process for preparing n-tritylimidazoles
YU30968A (en) Process for preparing alfa-6-deoxytetracycline
YU90067A (en) Process for preparing substituted 2-aminobenzimidazoles